PP
KZIA

Palladium Partners’s Kazia Therapeutics KZIA Stock Holding History

Palladium Partners’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1
Closed -$1K – 365
2014
Q1 		$1K Buy
+1
New +$852 ﹤0.01% 538
2013
Q4 		– Sell
-1
Closed -$1K – 366
2013
Q3 		$1K Hold
1
– – ﹤0.01% 553
2013
Q2 		$1K Buy
+1
New +$900 ﹤0.01% 571

Other funds holding KZIA

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
BWFA
Baltimore-Washington Financial Advisors Columbia, Maryland $2.32B AUM 16.8% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Palladium Partners's KZIA Position: Q2 2014 in Review

Palladium Partners sold out of Kazia Therapeutics (KZIA) in Q2 2014, closing a stake of 1 share — an estimated $1K sold.

Palladium Partners first reported a position in KZIA in Q2 2013 and held it in 3 quarters. The position peaked at $1K in Q1 2014. 7 funds tracked by Wall St. Rank hold KZIA as of Q2 2014.

  • Palladium Partners reported no remaining Kazia Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Palladium Partners sold 1 Kazia Therapeutics share in Q2 2014, an estimated $1K.
  • Palladium Partners first reported a position in Kazia Therapeutics in Q2 2013 and held it in 3 quarters.
  • Palladium Partners's Kazia Therapeutics position peaked at $1K in Q1 2014.
  • 7 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2014.

Based on Palladium Partners's 13F filing for Q2 2014, filed 1 Aug 2014.